| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium ion binding | JAG2 MMRN1 EYS FBN1 FBN2 NOTCH2NLB DLL4 FAT3 LRP1 LRP2 FLG2 DLL1 SLC25A23 NOTCH2 NOTCH3 CRB1 | 9.63e-12 | 749 | 48 | 16 | GO:0005509 |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 3.12e-07 | 188 | 48 | 7 | GO:0005201 | |
| GeneOntologyMolecularFunction | Notch binding | 4.95e-07 | 27 | 48 | 4 | GO:0005112 | |
| GeneOntologyMolecularFunction | extracellular matrix constituent conferring elasticity | 2.82e-06 | 12 | 48 | 3 | GO:0030023 | |
| GeneOntologyMolecularFunction | structural molecule activity conferring elasticity | 4.66e-06 | 14 | 48 | 3 | GO:0097493 | |
| GeneOntologyMolecularFunction | structural molecule activity | MMRN1 KRT26 FBN1 FBN2 MUC17 RPS2 TFPI2 OBSCN PAPLN FLG2 TECTA | 6.51e-06 | 891 | 48 | 11 | GO:0005198 |
| GeneOntologyMolecularFunction | signaling receptor regulator activity | 9.95e-05 | 616 | 48 | 8 | GO:0030545 | |
| GeneOntologyMolecularFunction | arachidonate-CoA ligase activity | 3.07e-04 | 11 | 48 | 2 | GO:0047676 | |
| GeneOntologyMolecularFunction | receptor ligand activity | 3.10e-04 | 547 | 48 | 7 | GO:0048018 | |
| GeneOntologyMolecularFunction | signaling receptor activator activity | 3.34e-04 | 554 | 48 | 7 | GO:0030546 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | 5.34e-04 | 599 | 48 | 7 | GO:0050839 | |
| GeneOntologyMolecularFunction | long-chain fatty acid-CoA ligase activity | 5.82e-04 | 15 | 48 | 2 | GO:0004467 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 6.65e-04 | 16 | 48 | 2 | GO:0005041 | |
| GeneOntologyMolecularFunction | integrin binding | 8.21e-04 | 175 | 48 | 4 | GO:0005178 | |
| GeneOntologyMolecularFunction | insulin-like growth factor binding | 9.43e-04 | 19 | 48 | 2 | GO:0005520 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 1.15e-03 | 21 | 48 | 2 | GO:0030228 | |
| GeneOntologyMolecularFunction | fatty acid ligase activity | 1.77e-03 | 26 | 48 | 2 | GO:0015645 | |
| GeneOntologyMolecularFunction | CoA-ligase activity | 1.91e-03 | 27 | 48 | 2 | GO:0016405 | |
| GeneOntologyMolecularFunction | serine-type endopeptidase inhibitor activity | 2.06e-03 | 105 | 48 | 3 | GO:0004867 | |
| GeneOntologyMolecularFunction | acid-thiol ligase activity | 2.52e-03 | 31 | 48 | 2 | GO:0016878 | |
| GeneOntologyMolecularFunction | PDZ domain binding | 3.22e-03 | 123 | 48 | 3 | GO:0030165 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor binding | 3.96e-03 | 39 | 48 | 2 | GO:0070325 | |
| GeneOntologyMolecularFunction | ligase activity, forming carbon-sulfur bonds | 4.37e-03 | 41 | 48 | 2 | GO:0016877 | |
| GeneOntologyBiologicalProcess | artery morphogenesis | 2.58e-06 | 92 | 49 | 5 | GO:0048844 | |
| GeneOntologyBiologicalProcess | positive regulation of Notch signaling pathway | 7.55e-06 | 53 | 49 | 4 | GO:0045747 | |
| GeneOntologyBiologicalProcess | Notch signaling pathway | 1.01e-05 | 210 | 49 | 6 | GO:0007219 | |
| GeneOntologyBiologicalProcess | artery development | 1.57e-05 | 133 | 49 | 5 | GO:0060840 | |
| GeneOntologyBiologicalProcess | positive regulation of long-chain fatty acid import across plasma membrane | 1.66e-05 | 3 | 49 | 2 | GO:0010747 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | JAG2 FBN2 DLL4 FAT3 KAT6A PKHD1 LRP2 CCN2 TECTA DLL1 NOTCH2 CRB1 | 3.07e-05 | 1269 | 49 | 12 | GO:0009887 |
| GeneOntologyBiologicalProcess | sequestering of TGFbeta in extracellular matrix | 3.31e-05 | 4 | 49 | 2 | GO:0035583 | |
| GeneOntologyBiologicalProcess | positive regulation of long-chain fatty acid import into cell | 3.31e-05 | 4 | 49 | 2 | GO:0140214 | |
| GeneOntologyBiologicalProcess | aorta development | 3.89e-05 | 80 | 49 | 4 | GO:0035904 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to growth factor stimulus | 5.02e-05 | 412 | 49 | 7 | GO:0090287 | |
| GeneOntologyBiologicalProcess | positive regulation of lysosomal protein catabolic process | 5.50e-05 | 5 | 49 | 2 | GO:1905167 | |
| GeneOntologyBiologicalProcess | chemoattraction of axon | 5.50e-05 | 5 | 49 | 2 | GO:0061642 | |
| GeneOntologyBiologicalProcess | neuron fate commitment | 6.45e-05 | 91 | 49 | 4 | GO:0048663 | |
| GeneOntologyBiologicalProcess | inner ear receptor cell fate commitment | 8.24e-05 | 6 | 49 | 2 | GO:0060120 | |
| GeneOntologyBiologicalProcess | glomerulus vasculature morphogenesis | 8.24e-05 | 6 | 49 | 2 | GO:0072103 | |
| GeneOntologyBiologicalProcess | glomerular capillary formation | 8.24e-05 | 6 | 49 | 2 | GO:0072104 | |
| GeneOntologyBiologicalProcess | auditory receptor cell fate commitment | 8.24e-05 | 6 | 49 | 2 | GO:0009912 | |
| GeneOntologyBiologicalProcess | positive regulation of cell population proliferation | TBC1D8 DLL4 PKHD1 LRP2 MARCHF7 REG1B CCN2 DLL1 ITGAL NOTCH2 NOTCH3 | 8.62e-05 | 1190 | 49 | 11 | GO:0008284 |
| GeneOntologyBiologicalProcess | positive regulation of lipid transport | 1.01e-04 | 102 | 49 | 4 | GO:0032370 | |
| GeneOntologyBiologicalProcess | renal system vasculature morphogenesis | 1.15e-04 | 7 | 49 | 2 | GO:0061438 | |
| GeneOntologyBiologicalProcess | kidney vasculature morphogenesis | 1.15e-04 | 7 | 49 | 2 | GO:0061439 | |
| GeneOntologyBiologicalProcess | positive regulation of protein catabolic process in the vacuole | 1.15e-04 | 7 | 49 | 2 | GO:1904352 | |
| GeneOntologyBiologicalProcess | regulation of long-chain fatty acid import across plasma membrane | 1.15e-04 | 7 | 49 | 2 | GO:0010746 | |
| GeneOntologyBiologicalProcess | aorta morphogenesis | 1.26e-04 | 41 | 49 | 3 | GO:0035909 | |
| GeneOntologyBiologicalProcess | cellular response to growth factor stimulus | 1.53e-04 | 850 | 49 | 9 | GO:0071363 | |
| GeneOntologyBiologicalProcess | maintenance of protein location in extracellular region | 1.53e-04 | 8 | 49 | 2 | GO:0071694 | |
| GeneOntologyBiologicalProcess | regulation of Notch signaling pathway | 1.55e-04 | 114 | 49 | 4 | GO:0008593 | |
| GeneOntologyBiologicalProcess | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 1.65e-04 | 218 | 49 | 5 | GO:0090101 | |
| GeneOntologyBiologicalProcess | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 1.65e-04 | 347 | 49 | 6 | GO:0090092 | |
| GeneOntologyBiologicalProcess | regulation of long-chain fatty acid import into cell | 1.97e-04 | 9 | 49 | 2 | GO:0140212 | |
| GeneOntologyBiologicalProcess | response to growth factor | 2.04e-04 | 883 | 49 | 9 | GO:0070848 | |
| GeneOntologyBiologicalProcess | cell fate determination | 2.28e-04 | 50 | 49 | 3 | GO:0001709 | |
| GeneOntologyBiologicalProcess | kidney development | 2.40e-04 | 372 | 49 | 6 | GO:0001822 | |
| GeneOntologyBiologicalProcess | marginal zone B cell differentiation | 2.46e-04 | 10 | 49 | 2 | GO:0002315 | |
| GeneOntologyBiologicalProcess | proximal tubule development | 2.46e-04 | 10 | 49 | 2 | GO:0072014 | |
| GeneOntologyBiologicalProcess | cholangiocyte proliferation | 2.46e-04 | 10 | 49 | 2 | GO:1990705 | |
| GeneOntologyBiologicalProcess | positive regulation of lipid localization | 2.49e-04 | 129 | 49 | 4 | GO:1905954 | |
| GeneOntologyBiologicalProcess | regulation of BMP signaling pathway | 2.64e-04 | 131 | 49 | 4 | GO:0030510 | |
| GeneOntologyBiologicalProcess | renal system development | 2.93e-04 | 386 | 49 | 6 | GO:0072001 | |
| GeneOntologyBiologicalProcess | glomerulus morphogenesis | 3.00e-04 | 11 | 49 | 2 | GO:0072102 | |
| GeneOntologyBiologicalProcess | sequestering of extracellular ligand from receptor | 3.00e-04 | 11 | 49 | 2 | GO:0035581 | |
| GeneOntologyBiologicalProcess | regulation of lysosomal protein catabolic process | 3.59e-04 | 12 | 49 | 2 | GO:1905165 | |
| GeneOntologyBiologicalProcess | long-chain fatty acid import across plasma membrane | 3.59e-04 | 12 | 49 | 2 | GO:0015911 | |
| GeneOntologyBiologicalProcess | heart development | 3.77e-04 | 757 | 49 | 8 | GO:0007507 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | 4.22e-04 | 1194 | 49 | 10 | GO:0000902 | |
| GeneOntologyBiologicalProcess | regulation of osteoclast development | 4.24e-04 | 13 | 49 | 2 | GO:2001204 | |
| GeneOntologyBiologicalProcess | extracellular regulation of signal transduction | 4.24e-04 | 13 | 49 | 2 | GO:1900115 | |
| GeneOntologyBiologicalProcess | extracellular negative regulation of signal transduction | 4.24e-04 | 13 | 49 | 2 | GO:1900116 | |
| GeneOntologyBiologicalProcess | cell-matrix adhesion | 4.41e-04 | 270 | 49 | 5 | GO:0007160 | |
| GeneOntologyBiologicalProcess | regulation of protein catabolic process in the vacuole | 4.94e-04 | 14 | 49 | 2 | GO:1904350 | |
| GeneOntologyBiologicalProcess | left/right axis specification | 4.94e-04 | 14 | 49 | 2 | GO:0070986 | |
| GeneOntologyBiologicalProcess | inner ear auditory receptor cell differentiation | 5.42e-04 | 67 | 49 | 3 | GO:0042491 | |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelium | 6.09e-04 | 619 | 49 | 7 | GO:0002009 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor superfamily signaling pathway | 6.22e-04 | 445 | 49 | 6 | GO:0141091 | |
| GeneOntologyBiologicalProcess | blood vessel morphogenesis | 6.25e-04 | 817 | 49 | 8 | GO:0048514 | |
| GeneOntologyBiologicalProcess | camera-type eye morphogenesis | 7.22e-04 | 171 | 49 | 4 | GO:0048593 | |
| GeneOntologyBiologicalProcess | hair cell differentiation | 8.46e-04 | 78 | 49 | 3 | GO:0035315 | |
| GeneOntologyBiologicalProcess | regulation of lipid transport | 8.57e-04 | 179 | 49 | 4 | GO:0032368 | |
| GeneOntologyBiologicalProcess | positive regulation of neural precursor cell proliferation | 9.10e-04 | 80 | 49 | 3 | GO:2000179 | |
| GeneOntologyBiologicalProcess | negative regulation of BMP signaling pathway | 9.10e-04 | 80 | 49 | 3 | GO:0030514 | |
| GeneOntologyBiologicalProcess | long-chain fatty-acyl-CoA biosynthetic process | 9.21e-04 | 19 | 49 | 2 | GO:0035338 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein serine/threonine kinase signaling pathway | 9.42e-04 | 482 | 49 | 6 | GO:0007178 | |
| GeneOntologyBiologicalProcess | heart morphogenesis | 9.63e-04 | 321 | 49 | 5 | GO:0003007 | |
| GeneOntologyBiologicalProcess | long-chain fatty acid import into cell | 1.02e-03 | 20 | 49 | 2 | GO:0044539 | |
| GeneOntologyBiologicalProcess | transport across blood-brain barrier | 1.16e-03 | 87 | 49 | 3 | GO:0150104 | |
| GeneOntologyBiologicalProcess | blood vessel remodeling | 1.16e-03 | 87 | 49 | 3 | GO:0001974 | |
| GeneOntologyBiologicalProcess | tube morphogenesis | 1.18e-03 | 1125 | 49 | 9 | GO:0035239 | |
| GeneOntologyBiologicalProcess | vascular transport | 1.20e-03 | 88 | 49 | 3 | GO:0010232 | |
| GeneOntologyBiologicalProcess | cell fate commitment | 1.21e-03 | 338 | 49 | 5 | GO:0045165 | |
| GeneOntologyBiologicalProcess | BMP signaling pathway | 1.22e-03 | 197 | 49 | 4 | GO:0030509 | |
| GeneOntologyBiologicalProcess | osteoclast development | 1.24e-03 | 22 | 49 | 2 | GO:0036035 | |
| GeneOntologyBiologicalProcess | bone cell development | 1.24e-03 | 22 | 49 | 2 | GO:0098751 | |
| GeneOntologyBiologicalProcess | fatty acid transmembrane transport | 1.24e-03 | 22 | 49 | 2 | GO:1902001 | |
| GeneOntologyBiologicalProcess | retina morphogenesis in camera-type eye | 1.28e-03 | 90 | 49 | 3 | GO:0060042 | |
| GeneOntologyBiologicalProcess | sensory organ morphogenesis | 1.29e-03 | 343 | 49 | 5 | GO:0090596 | |
| GeneOntologyBiologicalProcess | cell adhesion mediated by integrin | 1.32e-03 | 91 | 49 | 3 | GO:0033627 | |
| GeneOntologyBiologicalProcess | regulation of neurogenesis | 1.32e-03 | 515 | 49 | 6 | GO:0050767 | |
| GeneOntologyBiologicalProcess | negative regulation of cilium assembly | 1.35e-03 | 23 | 49 | 2 | GO:1902018 | |
| GeneOntologyBiologicalProcess | eye morphogenesis | 1.39e-03 | 204 | 49 | 4 | GO:0048592 | |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | 1.39e-03 | 713 | 49 | 7 | GO:0048598 | |
| GeneOntologyBiologicalProcess | blood vessel development | 1.43e-03 | 929 | 49 | 8 | GO:0001568 | |
| GeneOntologyBiologicalProcess | tube development | 1.46e-03 | 1402 | 49 | 10 | GO:0035295 | |
| GeneOntologyBiologicalProcess | lysosomal protein catabolic process | 1.48e-03 | 24 | 49 | 2 | GO:1905146 | |
| GeneOntologyBiologicalProcess | transcytosis | 1.48e-03 | 24 | 49 | 2 | GO:0045056 | |
| GeneOntologyBiologicalProcess | inner ear receptor cell differentiation | 1.54e-03 | 96 | 49 | 3 | GO:0060113 | |
| GeneOntologyBiologicalProcess | retina development in camera-type eye | 1.57e-03 | 211 | 49 | 4 | GO:0060041 | |
| GeneOntologyBiologicalProcess | sensory organ development | 1.59e-03 | 730 | 49 | 7 | GO:0007423 | |
| GeneOntologyBiologicalProcess | cardiac chamber development | 1.60e-03 | 212 | 49 | 4 | GO:0003205 | |
| GeneOntologyBiologicalProcess | lipid import into cell | 1.60e-03 | 25 | 49 | 2 | GO:0140354 | |
| GeneOntologyBiologicalProcess | retina layer formation | 1.60e-03 | 25 | 49 | 2 | GO:0010842 | |
| GeneOntologyBiologicalProcess | detection of light stimulus involved in visual perception | 1.60e-03 | 25 | 49 | 2 | GO:0050908 | |
| GeneOntologyBiologicalProcess | detection of light stimulus involved in sensory perception | 1.60e-03 | 25 | 49 | 2 | GO:0050962 | |
| GeneOntologyBiologicalProcess | positive regulation of endocytosis | 1.63e-03 | 213 | 49 | 4 | GO:0045807 | |
| GeneOntologyBiologicalProcess | regulation of lipid localization | 1.68e-03 | 215 | 49 | 4 | GO:1905952 | |
| GeneOntologyBiologicalProcess | response to BMP | 1.68e-03 | 215 | 49 | 4 | GO:0071772 | |
| GeneOntologyBiologicalProcess | cellular response to BMP stimulus | 1.68e-03 | 215 | 49 | 4 | GO:0071773 | |
| GeneOntologyBiologicalProcess | circulatory system development | 1.80e-03 | 1442 | 49 | 10 | GO:0072359 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | 1.83e-03 | 748 | 49 | 7 | GO:0048667 | |
| GeneOntologyBiologicalProcess | neural retina development | 1.83e-03 | 102 | 49 | 3 | GO:0003407 | |
| GeneOntologyBiologicalProcess | tissue morphogenesis | 1.86e-03 | 750 | 49 | 7 | GO:0048729 | |
| GeneOntologyCellularComponent | extracellular matrix | MMRN1 LAMB4 EYS FBN1 FBN2 ADAMTS4 MUC17 TFPI2 PAPLN LINGO3 REG1B CCN2 TECTA | 2.36e-09 | 656 | 49 | 13 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | MMRN1 LAMB4 EYS FBN1 FBN2 ADAMTS4 MUC17 TFPI2 PAPLN LINGO3 REG1B CCN2 TECTA | 2.45e-09 | 658 | 49 | 13 | GO:0030312 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 3.41e-07 | 530 | 49 | 10 | GO:0062023 | |
| GeneOntologyCellularComponent | microfibril | 4.13e-04 | 13 | 49 | 2 | GO:0001527 | |
| HumanPheno | Oliguria | 2.90e-05 | 17 | 19 | 3 | HP:0100520 | |
| HumanPheno | Abnormal upper to lower segment ratio | 3.95e-05 | 3 | 19 | 2 | HP:0012772 | |
| MousePheno | abnormal capillary morphology | 6.40e-06 | 93 | 40 | 5 | MP:0003658 | |
| MousePheno | abnormal aorta morphology | 3.95e-05 | 225 | 40 | 6 | MP:0000272 | |
| MousePheno | abnormal vertebrae morphology | 1.31e-04 | 546 | 40 | 8 | MP:0000137 | |
| MousePheno | perinatal lethality, complete penetrance | 1.44e-04 | 712 | 40 | 9 | MP:0011089 | |
| MousePheno | abnormal systemic artery morphology | 2.07e-04 | 304 | 40 | 6 | MP:0011655 | |
| MousePheno | abnormal artery morphology | 2.21e-04 | 440 | 40 | 7 | MP:0002191 | |
| MousePheno | increased kidney apoptosis | 2.47e-04 | 43 | 40 | 3 | MP:0011368 | |
| MousePheno | decreased kidney cell proliferation | 2.84e-04 | 9 | 40 | 2 | MP:0011441 | |
| MousePheno | abnormal vertebral column morphology | 3.06e-04 | 787 | 40 | 9 | MP:0004703 | |
| MousePheno | abnormal glomerular capillary morphology | 3.23e-04 | 47 | 40 | 3 | MP:0011320 | |
| MousePheno | abnormal kidney capillary morphology | 3.43e-04 | 48 | 40 | 3 | MP:0011310 | |
| MousePheno | decreased bone mineral density | 3.57e-04 | 476 | 40 | 7 | MP:0000063 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | JAG2 MMRN1 EYS FBN1 FBN2 DLL4 FAT3 LRP1 LRP2 DLL1 NOTCH2 NOTCH3 CRB1 | 4.85e-19 | 106 | 48 | 13 | IPR000152 |
| Domain | EGF_1 | JAG2 MMRN1 LAMB4 EYS FBN1 FBN2 DLL4 MUC17 FAT3 LRP1 LRP2 ADAM2 DLL1 NOTCH2 NOTCH3 CRB1 | 1.39e-18 | 255 | 48 | 16 | PS00022 |
| Domain | EGF_2 | JAG2 MMRN1 LAMB4 EYS FBN1 FBN2 DLL4 MUC17 FAT3 LRP1 LRP2 ADAM2 DLL1 NOTCH2 NOTCH3 CRB1 | 2.57e-18 | 265 | 48 | 16 | PS01186 |
| Domain | EGF_CA | JAG2 MMRN1 EYS FBN1 FBN2 DLL4 FAT3 LRP1 LRP2 DLL1 NOTCH2 NOTCH3 CRB1 | 3.25e-18 | 122 | 48 | 13 | SM00179 |
| Domain | EGF-like_Ca-bd_dom | JAG2 MMRN1 EYS FBN1 FBN2 DLL4 FAT3 LRP1 LRP2 DLL1 NOTCH2 NOTCH3 CRB1 | 4.05e-18 | 124 | 48 | 13 | IPR001881 |
| Domain | EGF_3 | JAG2 MMRN1 EYS FBN1 FBN2 DLL4 MUC17 FAT3 LRP1 LRP2 ADAM2 DLL1 NOTCH2 NOTCH3 CRB1 | 1.51e-17 | 235 | 48 | 15 | PS50026 |
| Domain | EGF | JAG2 MMRN1 EYS FBN1 FBN2 DLL4 MUC17 FAT3 LRP1 LRP2 TECTA DLL1 NOTCH2 NOTCH3 CRB1 | 1.51e-17 | 235 | 48 | 15 | SM00181 |
| Domain | ASX_HYDROXYL | JAG2 EYS FBN1 FBN2 DLL4 FAT3 LRP1 LRP2 DLL1 NOTCH2 NOTCH3 CRB1 | 1.67e-17 | 100 | 48 | 12 | PS00010 |
| Domain | EGF-like_dom | JAG2 MMRN1 EYS FBN1 FBN2 DLL4 MUC17 FAT3 LRP1 LRP2 TECTA DLL1 NOTCH2 NOTCH3 CRB1 | 3.62e-17 | 249 | 48 | 15 | IPR000742 |
| Domain | EGF-like_CS | JAG2 MMRN1 LAMB4 EYS FBN1 FBN2 DLL4 MUC17 FAT3 LRP1 LRP2 DLL1 NOTCH2 NOTCH3 CRB1 | 7.33e-17 | 261 | 48 | 15 | IPR013032 |
| Domain | Growth_fac_rcpt_ | JAG2 EYS FBN1 FBN2 CRIM1 DLL4 LRP1 LRP2 CCN2 DLL1 NOTCH2 NOTCH3 CRB1 | 8.69e-17 | 156 | 48 | 13 | IPR009030 |
| Domain | EGF_Ca-bd_CS | 7.97e-16 | 97 | 48 | 11 | IPR018097 | |
| Domain | EGF_CA | 1.01e-15 | 99 | 48 | 11 | PS01187 | |
| Domain | EGF | 1.54e-14 | 126 | 48 | 11 | PF00008 | |
| Domain | hEGF | 5.33e-13 | 28 | 48 | 7 | PF12661 | |
| Domain | EGF_CA | 4.71e-11 | 86 | 48 | 8 | PF07645 | |
| Domain | DSL | 6.36e-08 | 4 | 48 | 3 | PF01414 | |
| Domain | DSL | 6.36e-08 | 4 | 48 | 3 | SM00051 | |
| Domain | DSL | 1.59e-07 | 5 | 48 | 3 | IPR001774 | |
| Domain | DSL | 1.59e-07 | 5 | 48 | 3 | PS51051 | |
| Domain | Notch_ligand_N | 1.59e-07 | 5 | 48 | 3 | IPR011651 | |
| Domain | MNNL | 1.59e-07 | 5 | 48 | 3 | PF07657 | |
| Domain | cEGF | 5.51e-07 | 26 | 48 | 4 | IPR026823 | |
| Domain | cEGF | 5.51e-07 | 26 | 48 | 4 | PF12662 | |
| Domain | VWC | 2.66e-06 | 38 | 48 | 4 | SM00214 | |
| Domain | VWFC_2 | 2.66e-06 | 38 | 48 | 4 | PS50184 | |
| Domain | VWF_dom | 4.00e-06 | 42 | 48 | 4 | IPR001007 | |
| Domain | VWC_out | 1.50e-05 | 19 | 48 | 3 | SM00215 | |
| Domain | EGF_extracell | 1.68e-05 | 60 | 48 | 4 | IPR013111 | |
| Domain | EGF_2 | 1.68e-05 | 60 | 48 | 4 | PF07974 | |
| Domain | DUF3454 | 1.94e-05 | 3 | 48 | 2 | PF11936 | |
| Domain | DUF3454_notch | 1.94e-05 | 3 | 48 | 2 | IPR024600 | |
| Domain | DUF3454 | 1.94e-05 | 3 | 48 | 2 | SM01334 | |
| Domain | FBN | 1.94e-05 | 3 | 48 | 2 | IPR011398 | |
| Domain | Notch | 3.87e-05 | 4 | 48 | 2 | IPR008297 | |
| Domain | NODP | 3.87e-05 | 4 | 48 | 2 | PF07684 | |
| Domain | Notch_NODP_dom | 3.87e-05 | 4 | 48 | 2 | IPR011656 | |
| Domain | Notch_NOD_dom | 3.87e-05 | 4 | 48 | 2 | IPR010660 | |
| Domain | NOD | 3.87e-05 | 4 | 48 | 2 | PF06816 | |
| Domain | NOD | 3.87e-05 | 4 | 48 | 2 | SM01338 | |
| Domain | NODP | 3.87e-05 | 4 | 48 | 2 | SM01339 | |
| Domain | LNR | 6.44e-05 | 5 | 48 | 2 | PS50258 | |
| Domain | VWFC_1 | 1.07e-04 | 36 | 48 | 3 | PS01208 | |
| Domain | LAM_G_DOMAIN | 1.26e-04 | 38 | 48 | 3 | PS50025 | |
| Domain | TB | 1.35e-04 | 7 | 48 | 2 | PF00683 | |
| Domain | Notch_dom | 1.35e-04 | 7 | 48 | 2 | IPR000800 | |
| Domain | Notch | 1.35e-04 | 7 | 48 | 2 | PF00066 | |
| Domain | NL | 1.35e-04 | 7 | 48 | 2 | SM00004 | |
| Domain | Laminin_G_2 | 1.47e-04 | 40 | 48 | 3 | PF02210 | |
| Domain | - | 1.79e-04 | 8 | 48 | 2 | 3.90.290.10 | |
| Domain | LamG | 1.96e-04 | 44 | 48 | 3 | SM00282 | |
| Domain | TB | 2.30e-04 | 9 | 48 | 2 | PS51364 | |
| Domain | TB_dom | 2.30e-04 | 9 | 48 | 2 | IPR017878 | |
| Domain | Laminin_G | 4.45e-04 | 58 | 48 | 3 | IPR001791 | |
| Domain | TSP_1 | 5.68e-04 | 63 | 48 | 3 | PF00090 | |
| Domain | TIL_dom | 5.77e-04 | 14 | 48 | 2 | IPR002919 | |
| Domain | Ldl_recept_b | 5.77e-04 | 14 | 48 | 2 | PF00058 | |
| Domain | LDLRB | 5.77e-04 | 14 | 48 | 2 | PS51120 | |
| Domain | TSP1 | 6.22e-04 | 65 | 48 | 3 | SM00209 | |
| Domain | TSP1_rpt | 6.22e-04 | 65 | 48 | 3 | IPR000884 | |
| Domain | TSP1 | 6.22e-04 | 65 | 48 | 3 | PS50092 | |
| Domain | LY | 6.65e-04 | 15 | 48 | 2 | SM00135 | |
| Domain | LDLR_classB_rpt | 6.65e-04 | 15 | 48 | 2 | IPR000033 | |
| Domain | - | 9.64e-04 | 18 | 48 | 2 | 4.10.410.10 | |
| Domain | Prtase_inh_Kunz-CS | 9.64e-04 | 18 | 48 | 2 | IPR020901 | |
| Domain | IB | 9.64e-04 | 18 | 48 | 2 | SM00121 | |
| Domain | KU | 9.64e-04 | 18 | 48 | 2 | SM00131 | |
| Domain | BPTI_KUNITZ_2 | 1.08e-03 | 19 | 48 | 2 | PS50279 | |
| Domain | Kunitz_BPTI | 1.08e-03 | 19 | 48 | 2 | PF00014 | |
| Domain | BPTI_KUNITZ_1 | 1.08e-03 | 19 | 48 | 2 | PS00280 | |
| Domain | IGFBP-like | 1.19e-03 | 20 | 48 | 2 | IPR000867 | |
| Domain | IGFBP | 1.19e-03 | 20 | 48 | 2 | PF00219 | |
| Domain | IGFBP_N_2 | 1.19e-03 | 20 | 48 | 2 | PS51323 | |
| Domain | ADAM_spacer1 | 1.58e-03 | 23 | 48 | 2 | IPR010294 | |
| Domain | ADAM_spacer1 | 1.58e-03 | 23 | 48 | 2 | PF05986 | |
| Domain | Kunitz_BPTI | 1.58e-03 | 23 | 48 | 2 | IPR002223 | |
| Domain | Peptidase_M12B_ADAM-TS | 1.72e-03 | 24 | 48 | 2 | IPR013273 | |
| Domain | - | 1.87e-03 | 95 | 48 | 3 | 2.60.120.200 | |
| Domain | AMP-binding_CS | 2.02e-03 | 26 | 48 | 2 | IPR020845 | |
| Domain | ACR | 2.18e-03 | 27 | 48 | 2 | SM00608 | |
| Domain | ADAM_Cys-rich | 2.18e-03 | 27 | 48 | 2 | IPR006586 | |
| Domain | AMP_BINDING | 2.34e-03 | 28 | 48 | 2 | PS00455 | |
| Domain | VWC | 2.34e-03 | 28 | 48 | 2 | PF00093 | |
| Domain | ConA-like_dom | 2.39e-03 | 219 | 48 | 4 | IPR013320 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_SIGNALING_PATHWAY | 8.88e-11 | 13 | 35 | 5 | M47423 | |
| Pathway | WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING | 5.44e-09 | 27 | 35 | 5 | M39545 | |
| Pathway | WP_NOTCH_SIGNALING_WP268 | 7.97e-08 | 45 | 35 | 5 | M39571 | |
| Pathway | WP_NOTCH_SIGNALING_PATHWAY | 8.92e-08 | 46 | 35 | 5 | MM15971 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 9.97e-08 | 47 | 35 | 5 | M7946 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 1.20e-07 | 19 | 35 | 4 | MM15594 | |
| Pathway | REACTOME_NOTCH2_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS | 2.26e-07 | 22 | 35 | 4 | M27210 | |
| Pathway | PID_NOTCH_PATHWAY | 3.19e-07 | 59 | 35 | 5 | M17 | |
| Pathway | WP_NOTCH_SIGNALING_WP61 | 3.77e-07 | 61 | 35 | 5 | M39540 | |
| Pathway | REACTOME_NOTCH3_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS | 3.88e-07 | 25 | 35 | 4 | M27879 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_T_7_9_NOTCH1_M1580_K2555_TRANSLOCATION_MUTANT | 4.87e-07 | 7 | 35 | 3 | M27199 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_LIGAND_UBIQUITYLATION | 1.17e-06 | 9 | 35 | 3 | M47866 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH2 | 1.24e-06 | 33 | 35 | 4 | M604 | |
| Pathway | WP_DELTANOTCH_SIGNALING_PATHWAY | 1.67e-06 | 82 | 35 | 5 | MM15922 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 2.46e-06 | 39 | 35 | 4 | MM14604 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 6.23e-06 | 49 | 35 | 4 | M618 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_HD_DOMAIN_MUTANTS_IN_CANCER | 6.25e-06 | 15 | 35 | 3 | M27202 | |
| Pathway | KEGG_MEDICUS_VARIANT_NOTCH_OVEREXPRESSION_TO_NOTCH_SIGNALING_PATHWAY | 7.68e-06 | 16 | 35 | 3 | M47424 | |
| Pathway | WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION | 9.31e-06 | 17 | 35 | 3 | M39389 | |
| Pathway | WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES | 1.00e-05 | 118 | 35 | 5 | M39852 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 2.32e-05 | 68 | 35 | 4 | M27303 | |
| Pathway | WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE | 3.11e-05 | 25 | 35 | 3 | M39713 | |
| Pathway | WP_BREAST_CANCER_PATHWAY | 3.63e-05 | 154 | 35 | 5 | M39739 | |
| Pathway | WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER | 4.49e-05 | 161 | 35 | 5 | M39770 | |
| Pathway | REACTOME_DEFECTIVE_LFNG_CAUSES_SCDO3 | 5.96e-05 | 5 | 35 | 2 | M27411 | |
| Pathway | REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS | 6.01e-05 | 31 | 35 | 3 | M592 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_THE_ENDOPLASMIC_RETICULUM | 8.93e-05 | 6 | 35 | 2 | M27068 | |
| Pathway | WP_NEURAL_CREST_DIFFERENTIATION | 9.36e-05 | 97 | 35 | 4 | MM15926 | |
| Pathway | WP_NEURAL_CREST_DIFFERENTIATION | 1.10e-04 | 101 | 35 | 4 | M39448 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_E2_TO_NUCLEAR_INITIATED_ESTROGEN_SIGNALING_PATHWAY | 1.25e-04 | 7 | 35 | 2 | M47805 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_PROTEOLYTIC_ACTIVATION | 3.25e-04 | 11 | 35 | 2 | M47865 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BETA_OXIDATION_ACYL_COA_SYNTHESIS | 3.25e-04 | 11 | 35 | 2 | M47626 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 3.29e-04 | 246 | 35 | 5 | M10189 | |
| Pathway | BIOCARTA_HES_PATHWAY | 3.89e-04 | 12 | 35 | 2 | MM1562 | |
| Pathway | BIOCARTA_HES_PATHWAY | 3.89e-04 | 12 | 35 | 2 | M22042 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00380 | 3.89e-04 | 12 | 35 | 2 | M47532 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00381 | 3.89e-04 | 12 | 35 | 2 | M47533 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_PEST_DOMAIN_MUTANTS_IN_CANCER | 3.94e-04 | 58 | 35 | 3 | M29616 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 4.16e-04 | 143 | 35 | 4 | M27275 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00382 | 4.59e-04 | 13 | 35 | 2 | M47534 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1 | 8.05e-04 | 74 | 35 | 3 | M616 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | 8.94e-04 | 18 | 35 | 2 | M614 | |
| Pathway | WP_FATTY_ACID_TRANSPORTERS | 8.94e-04 | 18 | 35 | 2 | M42570 | |
| Pathway | WP_FATTY_ACID_BIOSYNTHESIS | 1.34e-03 | 22 | 35 | 2 | M39440 | |
| Pathway | REACTOME_SYNTHESIS_OF_VERY_LONG_CHAIN_FATTY_ACYL_COAS | 1.34e-03 | 22 | 35 | 2 | MM15451 | |
| Pathway | WP_CANCER_PATHWAYS | 1.40e-03 | 507 | 35 | 6 | M48302 | |
| Pathway | WP_FATTY_ACID_BIOSYNTHESIS | 1.47e-03 | 23 | 35 | 2 | MM15885 | |
| Pathway | REACTOME_SYNTHESIS_OF_VERY_LONG_CHAIN_FATTY_ACYL_COAS | 1.60e-03 | 24 | 35 | 2 | M1016 | |
| Pathway | KEGG_DORSO_VENTRAL_AXIS_FORMATION | 1.60e-03 | 24 | 35 | 2 | M11190 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 2.17e-03 | 28 | 35 | 2 | M6177 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 2.79e-03 | 114 | 35 | 3 | MM14571 | |
| Pathway | REACTOME_FATTY_ACYL_COA_BIOSYNTHESIS | 2.83e-03 | 32 | 35 | 2 | MM15446 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 2.83e-03 | 32 | 35 | 2 | MM14854 | |
| Pathway | WP_FATTY_ACID_BETAOXIDATION | 3.20e-03 | 34 | 35 | 2 | M39596 | |
| Pathway | WP_FATTY_ACID_BETAOXIDATION | 3.20e-03 | 34 | 35 | 2 | MM15937 | |
| Pathway | WP_OSX_AND_MIRNAS_IN_TOOTH_DEVELOPMENT | 3.20e-03 | 34 | 35 | 2 | M39390 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 3.28e-03 | 250 | 35 | 4 | M27554 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 3.67e-03 | 258 | 35 | 4 | MM14572 | |
| Pathway | WP_NEOVASCULARIZATION_PROCESSES | 3.78e-03 | 37 | 35 | 2 | M39506 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 3.78e-03 | 37 | 35 | 2 | M27134 | |
| Pathway | REACTOME_FATTY_ACYL_COA_BIOSYNTHESIS | 3.78e-03 | 37 | 35 | 2 | M729 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 4.19e-03 | 39 | 35 | 2 | MM14601 | |
| Pathway | PID_AMB2_NEUTROPHILS_PATHWAY | 4.62e-03 | 41 | 35 | 2 | M159 | |
| Pathway | KEGG_FATTY_ACID_METABOLISM | 4.84e-03 | 42 | 35 | 2 | M699 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 4.97e-03 | 140 | 35 | 3 | M587 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 5.31e-03 | 44 | 35 | 2 | M26969 | |
| Pathway | REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS | 5.54e-03 | 45 | 35 | 2 | MM15344 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 6.26e-03 | 300 | 35 | 4 | M610 | |
| Pathway | REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS | 6.29e-03 | 48 | 35 | 2 | M27642 | |
| Pubmed | 5.64e-13 | 9 | 49 | 5 | 16245338 | ||
| Pubmed | Spatiotemporal expression of Notch receptors and ligands in developing mouse placenta. | 1.13e-12 | 10 | 49 | 5 | 23665443 | |
| Pubmed | 3.54e-12 | 12 | 49 | 5 | 15465494 | ||
| Pubmed | Vascular expression of Notch pathway receptors and ligands is restricted to arterial vessels. | 5.74e-12 | 13 | 49 | 5 | 11578869 | |
| Pubmed | 8.92e-12 | 14 | 49 | 5 | 14757642 | ||
| Pubmed | 1.34e-11 | 15 | 49 | 5 | 12971992 | ||
| Pubmed | Expression patterns of Notch receptors and their ligands Jagged and Delta in human placenta. | 1.74e-11 | 5 | 49 | 4 | 21726900 | |
| Pubmed | Expression of Notch pathway components in fetal and adult mouse small intestine. | 1.94e-11 | 16 | 49 | 5 | 12617809 | |
| Pubmed | 1.94e-11 | 16 | 49 | 5 | 17273555 | ||
| Pubmed | 2.75e-11 | 17 | 49 | 5 | 18694942 | ||
| Pubmed | Segmental expression of Notch and Hairy genes in nephrogenesis. | 2.75e-11 | 17 | 49 | 5 | 15821257 | |
| Pubmed | 3.80e-11 | 18 | 49 | 5 | 18093989 | ||
| Pubmed | 3.80e-11 | 18 | 49 | 5 | 15689374 | ||
| Pubmed | 5.15e-11 | 19 | 49 | 5 | 16518823 | ||
| Pubmed | 6.68e-11 | 48 | 49 | 6 | 35247391 | ||
| Pubmed | 9.00e-11 | 21 | 49 | 5 | 28656980 | ||
| Pubmed | 1.16e-10 | 22 | 49 | 5 | 21750033 | ||
| Pubmed | 1.21e-10 | 7 | 49 | 4 | 10079256 | ||
| Pubmed | The distribution of Notch receptors and their ligands during articular cartilage development. | 1.21e-10 | 7 | 49 | 4 | 12846471 | |
| Pubmed | 1.49e-10 | 23 | 49 | 5 | 14701881 | ||
| Pubmed | 1.49e-10 | 23 | 49 | 5 | 24337118 | ||
| Pubmed | 2.42e-10 | 8 | 49 | 4 | 9858718 | ||
| Pubmed | 2.42e-10 | 8 | 49 | 4 | 11044610 | ||
| Pubmed | Notch signaling controls liver development by regulating biliary differentiation. | 2.89e-10 | 26 | 49 | 5 | 19369401 | |
| Pubmed | 4.36e-10 | 9 | 49 | 4 | 11118901 | ||
| Pubmed | 5.21e-10 | 29 | 49 | 5 | 25535917 | ||
| Pubmed | Notch signaling regulates ovarian follicle formation and coordinates follicular growth. | 6.24e-10 | 30 | 49 | 5 | 24552588 | |
| Pubmed | 7.25e-10 | 10 | 49 | 4 | 24015274 | ||
| Pubmed | 1.14e-09 | 11 | 49 | 4 | 10878608 | ||
| Pubmed | 1.14e-09 | 11 | 49 | 4 | 12866128 | ||
| Pubmed | 1.21e-09 | 34 | 49 | 5 | 21311046 | ||
| Pubmed | Notch signaling regulates smooth muscle differentiation of epicardium-derived cells. | 1.41e-09 | 35 | 49 | 5 | 21252157 | |
| Pubmed | Jagged1 is Essential for Radial Glial Maintenance in the Cortical Proliferative Zone. | 2.46e-09 | 13 | 49 | 4 | 31202705 | |
| Pubmed | Jagged2 acts as a Delta-like Notch ligand during early hematopoietic cell fate decisions. | 2.63e-09 | 3 | 49 | 3 | 21372153 | |
| Pubmed | 2.63e-09 | 3 | 49 | 3 | 28572448 | ||
| Pubmed | 3.25e-09 | 41 | 49 | 5 | 22675208 | ||
| Pubmed | The notch pathway positively regulates programmed cell death during erythroid differentiation. | 4.69e-09 | 44 | 49 | 5 | 17476283 | |
| Pubmed | 4.69e-09 | 15 | 49 | 4 | 17194759 | ||
| Pubmed | 4.69e-09 | 15 | 49 | 4 | 9291577 | ||
| Pubmed | Lunatic fringe, FGF, and BMP regulate the Notch pathway during epithelial morphogenesis of teeth. | 4.69e-09 | 15 | 49 | 4 | 12167404 | |
| Pubmed | COUP-TFI controls Notch regulation of hair cell and support cell differentiation. | 4.69e-09 | 15 | 49 | 4 | 16914494 | |
| Pubmed | 6.25e-09 | 16 | 49 | 4 | 10842072 | ||
| Pubmed | 6.25e-09 | 16 | 49 | 4 | 32161758 | ||
| Pubmed | 8.16e-09 | 17 | 49 | 4 | 39315665 | ||
| Pubmed | 9.09e-09 | 50 | 49 | 5 | 27510977 | ||
| Pubmed | Notch ligands transduce different magnitudes of signaling critical for determination of T-cell fate. | 1.05e-08 | 4 | 49 | 3 | 20602435 | |
| Pubmed | Canonical Notch ligands and Fringes have distinct effects on NOTCH1 and NOTCH2. | 1.05e-08 | 4 | 49 | 3 | 32820046 | |
| Pubmed | Fibroblastic niches prime T cell alloimmunity through Delta-like Notch ligands. | 1.05e-08 | 4 | 49 | 3 | 28319044 | |
| Pubmed | 1.05e-08 | 4 | 49 | 3 | 38462037 | ||
| Pubmed | 1.33e-08 | 19 | 49 | 4 | 20335360 | ||
| Pubmed | Physical interaction of Delta1, Jagged1, and Jagged2 with Notch1 and Notch3 receptors. | 2.62e-08 | 5 | 49 | 3 | 11006133 | |
| Pubmed | Functional diversity of notch family genes in fetal lung development. | 2.62e-08 | 5 | 49 | 3 | 15064243 | |
| Pubmed | 2.62e-08 | 5 | 49 | 3 | 23675950 | ||
| Pubmed | 2.62e-08 | 5 | 49 | 3 | 21602525 | ||
| Pubmed | 2.62e-08 | 5 | 49 | 3 | 16899352 | ||
| Pubmed | 2.62e-08 | 5 | 49 | 3 | 30181175 | ||
| Pubmed | Lunatic Fringe-mediated Notch signaling is required for lung alveogenesis. | 3.02e-08 | 23 | 49 | 4 | 19897741 | |
| Pubmed | 3.02e-08 | 23 | 49 | 4 | 36239412 | ||
| Pubmed | 5.24e-08 | 6 | 49 | 3 | 10958687 | ||
| Pubmed | Expression of Deltex1 during mouse embryogenesis: comparison with Notch1, 2 and 3 expression. | 5.24e-08 | 6 | 49 | 3 | 11731257 | |
| Pubmed | Aberrant expression of Notch signaling molecules in patients with immune thrombocytopenic purpura. | 5.24e-08 | 6 | 49 | 3 | 19603167 | |
| Pubmed | 5.24e-08 | 6 | 49 | 3 | 19217325 | ||
| Pubmed | 5.24e-08 | 6 | 49 | 3 | 9882480 | ||
| Pubmed | 5.46e-08 | 71 | 49 | 5 | 33541421 | ||
| Pubmed | Notch signaling prevents mucous metaplasia in mouse conducting airways during postnatal development. | 5.96e-08 | 27 | 49 | 4 | 21791528 | |
| Pubmed | 9.16e-08 | 7 | 49 | 3 | 10383933 | ||
| Pubmed | 9.16e-08 | 7 | 49 | 3 | 32060138 | ||
| Pubmed | Regulation of monocyte cell fate by blood vessels mediated by Notch signalling. | 9.16e-08 | 7 | 49 | 3 | 27576369 | |
| Pubmed | Differentiation of CD11c+ CX3CR1+ cells in the small intestine requires Notch signaling. | 9.16e-08 | 7 | 49 | 3 | 24711412 | |
| Pubmed | 9.16e-08 | 7 | 49 | 3 | 30289388 | ||
| Pubmed | 9.16e-08 | 7 | 49 | 3 | 16169548 | ||
| Pubmed | 9.27e-08 | 30 | 49 | 4 | 19054571 | ||
| Pubmed | Mind bomb 1 is essential for generating functional Notch ligands to activate Notch. | 1.38e-07 | 33 | 49 | 4 | 16000382 | |
| Pubmed | 1.44e-07 | 86 | 49 | 5 | 35103284 | ||
| Pubmed | 1.46e-07 | 8 | 49 | 3 | 16141228 | ||
| Pubmed | P4 down-regulates Jagged2 and Notch1 expression during primordial folliculogenesis. | 1.46e-07 | 8 | 49 | 3 | 22652674 | |
| Pubmed | Expression of Hairy/Enhancer of Split genes, Hes1 and Hes5, during murine nephron morphogenesis. | 1.46e-07 | 8 | 49 | 3 | 15465493 | |
| Pubmed | 1.56e-07 | 34 | 49 | 4 | 17015435 | ||
| Pubmed | The Retinal Pigment Epithelium Is a Notch Signaling Niche in the Mouse Retina. | 1.76e-07 | 35 | 49 | 4 | 28402857 | |
| Pubmed | Notch signaling is essential for vascular morphogenesis in mice. | 2.19e-07 | 9 | 49 | 3 | 10837027 | |
| Pubmed | 2.22e-07 | 37 | 49 | 4 | 24673559 | ||
| Pubmed | 3.06e-07 | 100 | 49 | 5 | 24859004 | ||
| Pubmed | Jag2-Notch1 signaling regulates oral epithelial differentiation and palate development. | 4.30e-07 | 11 | 49 | 3 | 16607638 | |
| Pubmed | Coexpression of Cux-1 and Notch signaling pathway components during kidney development. | 4.30e-07 | 11 | 49 | 3 | 15499562 | |
| Pubmed | A family of mammalian Fringe genes implicated in boundary determination and the Notch pathway. | 4.30e-07 | 11 | 49 | 3 | 9187150 | |
| Pubmed | 5.73e-07 | 12 | 49 | 3 | 10952889 | ||
| Pubmed | 5.73e-07 | 12 | 49 | 3 | 14732396 | ||
| Pubmed | 7.44e-07 | 13 | 49 | 3 | 11171333 | ||
| Pubmed | 7.44e-07 | 13 | 49 | 3 | 34838591 | ||
| Pubmed | 7.44e-07 | 13 | 49 | 3 | 23132245 | ||
| Pubmed | 1.45e-06 | 16 | 49 | 3 | 22464328 | ||
| Pubmed | Requirement of Math1 for secretory cell lineage commitment in the mouse intestine. | 1.45e-06 | 16 | 49 | 3 | 11739954 | |
| Pubmed | The Cellular Prion Protein Controls Notch Signaling in Neural Stem/Progenitor Cells. | 1.45e-06 | 16 | 49 | 3 | 27641601 | |
| Pubmed | 1.76e-06 | 17 | 49 | 3 | 10476967 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 12399449 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 21851253 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 12429739 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 14660750 | ||
| Pubmed | New Evidence Supporting the Role of FBN1 in the Development of Adolescent Idiopathic Scoliosis. | 1.94e-06 | 2 | 49 | 2 | 30044367 | |
| Pubmed | Material and mechanical properties of bones deficient for fibrillin-1 or fibrillin-2 microfibrils. | 1.94e-06 | 2 | 49 | 2 | 21440062 | |
| Interaction | NTN5 interactions | 1.51e-11 | 24 | 47 | 6 | int:NTN5 | |
| Interaction | ZFP41 interactions | 3.83e-09 | 57 | 47 | 6 | int:ZFP41 | |
| Interaction | MFAP5 interactions | 1.33e-07 | 52 | 47 | 5 | int:MFAP5 | |
| Interaction | IGFL3 interactions | 8.47e-07 | 75 | 47 | 5 | int:IGFL3 | |
| Interaction | ZNF408 interactions | 1.05e-06 | 145 | 47 | 6 | int:ZNF408 | |
| Interaction | MFAP2 interactions | 2.58e-06 | 12 | 47 | 3 | int:MFAP2 | |
| Interaction | ST14 interactions | 8.26e-06 | 207 | 47 | 6 | int:ST14 | |
| Interaction | ZDHHC15 interactions | 1.05e-05 | 125 | 47 | 5 | int:ZDHHC15 | |
| Interaction | ZNF224 interactions | 1.32e-05 | 20 | 47 | 3 | int:ZNF224 | |
| Interaction | NOTCH4 interactions | 1.54e-05 | 21 | 47 | 3 | int:NOTCH4 | |
| Interaction | MIB1 interactions | 6.06e-05 | 295 | 47 | 6 | int:MIB1 | |
| Interaction | LTBP1 interactions | 6.24e-05 | 92 | 47 | 4 | int:LTBP1 | |
| Interaction | GREM2 interactions | 8.74e-05 | 37 | 47 | 3 | int:GREM2 | |
| Interaction | DLL1 interactions | 9.47e-05 | 38 | 47 | 3 | int:DLL1 | |
| Interaction | CCN2 interactions | 1.11e-04 | 40 | 47 | 3 | int:CCN2 | |
| Interaction | JAG1 interactions | 1.19e-04 | 41 | 47 | 3 | int:JAG1 | |
| Interaction | NOTCH3 interactions | 1.39e-04 | 113 | 47 | 4 | int:NOTCH3 | |
| Interaction | WNT3A interactions | 2.03e-04 | 49 | 47 | 3 | int:WNT3A | |
| GeneFamily | Low density lipoprotein receptors | 2.64e-04 | 13 | 34 | 2 | 634 | |
| GeneFamily | Acyl-CoA synthetase family | 1.08e-03 | 26 | 34 | 2 | 40 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 3.39e-03 | 161 | 34 | 3 | 593 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 7.15e-11 | 16 | 48 | 5 | MM1296 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 7.15e-11 | 16 | 48 | 5 | M2207 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 7.93e-11 | 196 | 48 | 9 | M3008 | |
| Coexpression | NABA_CORE_MATRISOME | 1.59e-09 | 275 | 48 | 9 | M5884 | |
| Coexpression | NABA_MATRISOME | MMRN1 LAMB4 EYS FBN1 FBN2 CRIM1 ADAMTS4 MUC17 PAPLN REG1B CCN2 ADAM2 FLG2 TECTA | 2.53e-09 | 1026 | 48 | 14 | M5889 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 5.59e-08 | 191 | 48 | 7 | MM17059 | |
| Coexpression | NABA_MATRISOME | MMRN1 FBN1 FBN2 CRIM1 ADAMTS4 MUC17 PAPLN REG1B CCN2 ADAM2 FLG2 TECTA | 1.90e-07 | 1008 | 48 | 12 | MM17056 |
| Coexpression | NABA_CORE_MATRISOME | 5.85e-07 | 270 | 48 | 7 | MM17057 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL3 | 8.53e-07 | 574 | 48 | 9 | M39056 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 1.72e-06 | 200 | 48 | 6 | M5930 | |
| Coexpression | JONES_OVARY_NK_CELL | 2.16e-05 | 89 | 48 | 4 | M48353 | |
| Coexpression | HALLMARK_NOTCH_SIGNALING | 2.75e-05 | 32 | 48 | 3 | M5903 | |
| Coexpression | GSE35543_IN_VIVO_NTREG_VS_IN_VITRO_ITREG_UP | 3.15e-05 | 199 | 48 | 5 | M9430 | |
| Coexpression | CERVERA_SDHB_TARGETS_2 | 5.89e-05 | 115 | 48 | 4 | M19068 | |
| Coexpression | SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER | 8.83e-05 | 47 | 48 | 3 | M11213 | |
| Coexpression | VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN | 1.10e-04 | 135 | 48 | 4 | M5825 | |
| Coexpression | KOMMAGANI_TP63_GAMMA_TARGETS | 1.17e-04 | 9 | 48 | 2 | M9630 | |
| Coexpression | ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_UP | 1.23e-04 | 139 | 48 | 4 | M6754 | |
| Coexpression | KYNG_DNA_DAMAGE_BY_4NQO_OR_UV | 1.83e-04 | 60 | 48 | 3 | M1816 | |
| Coexpression | VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP | 2.27e-04 | 163 | 48 | 4 | M12112 | |
| Coexpression | SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP | 2.35e-04 | 305 | 48 | 5 | M19875 | |
| Coexpression | AIZARANI_LIVER_C29_MVECS_2 | 2.64e-04 | 313 | 48 | 5 | M39128 | |
| Coexpression | JONES_OVARY_PERICYTE | 2.78e-04 | 172 | 48 | 4 | M48351 | |
| Coexpression | MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH | 3.40e-04 | 15 | 48 | 2 | M6900 | |
| CoexpressionAtlas | JC_hmvEC_top-relative-expression-ranked_500 | 1.17e-05 | 495 | 47 | 8 | JC_hmvEC_500 | |
| CoexpressionAtlas | JC_hmvEC_top-relative-expression-ranked_1000 | 4.97e-05 | 990 | 47 | 10 | JC_hmvEC_1000 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-08 | 160 | 49 | 6 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-08 | 160 | 49 | 6 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.21e-08 | 184 | 49 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.21e-08 | 184 | 49 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.21e-08 | 184 | 49 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | PND07-28-samps-Endothelial-Postnatal_endothelial-endothelial_cells_D|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 4.64e-07 | 140 | 49 | 5 | b9aeb7dda7f377b580dd8a44912f300721437387 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.52e-07 | 145 | 49 | 5 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.54e-07 | 162 | 49 | 5 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.21e-06 | 170 | 49 | 5 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.65e-06 | 181 | 49 | 5 | 6956ecd6264f7469a25e555673bce4eb97d28f7a | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.74e-06 | 183 | 49 | 5 | 92fbd83a9d13ee91065cbd479fb298f1fd564568 | |
| ToppCell | PCW_07-8.5-Endothelial-Endothelial_mature-endo_arterial_(9)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.09e-06 | 190 | 49 | 5 | 1307688255a1250fa300edf2c41f1affe31dcc98 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-B_(Artery)|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.31e-06 | 194 | 49 | 5 | f8a59bd4609d147d8a706bf606e9e8173c9992a3 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.31e-06 | 194 | 49 | 5 | f44394c8a6f86483063f2f5722f003a8a0a70254 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-B_(Artery)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.31e-06 | 194 | 49 | 5 | 04b1acc2e879feafb43f75435281c5acd8d23be2 | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 2.31e-06 | 194 | 49 | 5 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.31e-06 | 194 | 49 | 5 | 8ddcaaf24cee6e30d5be52c0cbf778cfba309c53 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.37e-06 | 195 | 49 | 5 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.37e-06 | 195 | 49 | 5 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.49e-06 | 197 | 49 | 5 | 9244f087ba4b60fdc81d54ce91860de715b3e12c | |
| ToppCell | 390C-Endothelial_cells|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.49e-06 | 197 | 49 | 5 | aa381acea0f7882d39435a6f713386bf0588b5f8 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.56e-06 | 198 | 49 | 5 | 218f33e068eb126458ec33176de3cfa6fc06ddf0 | |
| ToppCell | severe-HLA-DR+_CD83+_Monocyte|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.56e-06 | 198 | 49 | 5 | a77f3440d7fb6a50066abc7e9ad59e83798ef13d | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.56e-06 | 198 | 49 | 5 | e1fa02184ce93c4f8aa5cf04b70949cd4c425ff0 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.56e-06 | 198 | 49 | 5 | 7cddd474416651088a4e08edfc0ac420ff10a5fe | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.62e-06 | 199 | 49 | 5 | e78f661b40da34768469549b6e755d330be6bbd8 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_2|Control_saline / Treatment groups by lineage, cell group, cell type | 2.69e-06 | 200 | 49 | 5 | bc8949eb34482aca166c4602ff6ab876cb4c2c3c | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.42e-05 | 153 | 49 | 4 | d6526d17826470534b766df144c74e73eb83fdad | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.54e-05 | 155 | 49 | 4 | 8fdda4e3657ac56188ae88ed3caf145f4d9d1567 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Myeloid-myeloid_leukocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.88e-05 | 160 | 49 | 4 | 237430af14830b38e58da8a4224036e5c6b71c5b | |
| ToppCell | droplet-Spleen-nan-21m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.57e-05 | 169 | 49 | 4 | 7962165cab84af73d20b56eb70b1ed87c94025ef | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.57e-05 | 169 | 49 | 4 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.65e-05 | 170 | 49 | 4 | 55fe16d98ea284d05fb899888e4569c685644c7b | |
| ToppCell | droplet-Spleen-nan-18m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.73e-05 | 171 | 49 | 4 | 4e856441063e9825b6f87a1d3dd19c77dae4662c | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.09e-05 | 175 | 49 | 4 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.18e-05 | 176 | 49 | 4 | 327a3e81b724252e36d786de92a3ffd721ea6d7b | |
| ToppCell | wk_20-22-Endothelial-Blood_vessel_endothelial-OMD+_endo|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 4.18e-05 | 176 | 49 | 4 | 52af8f717dbd3b59eeb868b8b7b256a8f3e57d7a | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.37e-05 | 178 | 49 | 4 | 544379f5a6145429762258d426b876bb36c112f5 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.46e-05 | 179 | 49 | 4 | a1ea8daa0fe8900f5a04b555c77fe8ebdaa3908d | |
| ToppCell | PCW_05-06-Endothelial-Endothelial_mature-endo_arterial_(9)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.56e-05 | 180 | 49 | 4 | 5861b44acfb8fe92c281c8355bf19c059b3dcd64 | |
| ToppCell | metastatic_Brain-Fibroblasts-Myofibroblasts|metastatic_Brain / Location, Cell class and cell subclass | 4.66e-05 | 181 | 49 | 4 | bd0b5f74f9c81ec0f1592710774a4fdf33d9d5a9 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.86e-05 | 183 | 49 | 4 | 8a799807fbf24456a9811e0c64068187940a2f71 | |
| ToppCell | COPD-Endothelial-VE_Venous|COPD / Disease state, Lineage and Cell class | 4.97e-05 | 184 | 49 | 4 | 44d716e7ba46a1ed03f5992631289653f8fd7d5e | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.97e-05 | 184 | 49 | 4 | 327ff3ac8d2fecdd5d242bdc34f0dfdb1c59a68b | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 5.18e-05 | 186 | 49 | 4 | cb1fc4b9140666b43415e21c9b434dc9b144e9d0 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.18e-05 | 186 | 49 | 4 | 5473283fb95cee556b1f6934cf72169b676b5bcc | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.18e-05 | 186 | 49 | 4 | 5784d255e9ca449d375d81938d0fbbd8a7eb44f6 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_vein|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.29e-05 | 187 | 49 | 4 | e35716f8b482be3bf5ab79f087a9caf67a9d197a | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.29e-05 | 187 | 49 | 4 | 4e553721fa5598cb211f44e3226280b7e6885484 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.29e-05 | 187 | 49 | 4 | d36e7fc6125e7a4310499365022d38f34b757a73 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.29e-05 | 187 | 49 | 4 | 827eae63fabf6892a82ce7779b5f395958d3d628 | |
| ToppCell | PCW_05-06-Endothelial-Endothelial_mature-endo_venous_(13)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 5.29e-05 | 187 | 49 | 4 | 03de3c2df31bca0dc4e3718bada708d8fe8b69b9 | |
| ToppCell | wk_15-18-Endothelial-Blood_vessel_endothelial-GRIA2+_arterial_endo|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.40e-05 | 188 | 49 | 4 | 366a2d59b9c81d8a7659749f9c07efa46b49a39a | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.40e-05 | 188 | 49 | 4 | 997dcfc4f08738ab398d8abc15e4fd2fc6619862 | |
| ToppCell | Control-Endothelial-VE_Venous|World / Disease state, Lineage and Cell class | 5.51e-05 | 189 | 49 | 4 | f83f7521e377ded1522639e9a35c98b3e2725bac | |
| ToppCell | P03-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.51e-05 | 189 | 49 | 4 | b5439ef221106f6d54434f268485e9bb17b39102 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.51e-05 | 189 | 49 | 4 | 45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.63e-05 | 190 | 49 | 4 | 4eb92aef1ee868f4537483d19014d947b7684612 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.63e-05 | 190 | 49 | 4 | 06bfb62b94b0faf467ef93d5bc5d08924c770098 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.63e-05 | 190 | 49 | 4 | 7be4341e2909101d756f14031c21e705eb45e69a | |
| ToppCell | Control-Endothelial-VE_Venous|Control / Disease state, Lineage and Cell class | 5.74e-05 | 191 | 49 | 4 | 617546cf4883dedf3323e03a53ba5adec334cf8e | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 5.74e-05 | 191 | 49 | 4 | 78c3c2fdb68c3407f2436f90e1e6a780bbf8b79e | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Endothelial-endothelial_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.86e-05 | 192 | 49 | 4 | 945153c41dde6e90d103206955e1707b54eb0665 | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Endothelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.86e-05 | 192 | 49 | 4 | 6ab50579c63f31ca2cd41063a99b129f11c07510 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-SVEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.86e-05 | 192 | 49 | 4 | c3dda7c48732b0b8bde36de282d64192f5e9b98f | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.86e-05 | 192 | 49 | 4 | df1545670370fb1010c567cd059c2783eab315f7 | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.86e-05 | 192 | 49 | 4 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.98e-05 | 193 | 49 | 4 | 3f8280ef849d95b2fcea5e6824b95a07febc96d0 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.98e-05 | 193 | 49 | 4 | ffa1932da2979d7b63dbac32eb5788346a3f5b2a | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.98e-05 | 193 | 49 | 4 | 0f2167eef8203a5659c8c72e4e77646003d64797 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.98e-05 | 193 | 49 | 4 | 800b0f5705fefcd3608e37801afae8a94474723e | |
| ToppCell | LA|World / Chamber and Cluster_Paper | 5.98e-05 | 193 | 49 | 4 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | IPF-Endothelial-VE_Arterial|World / Disease state, Lineage and Cell class | 5.98e-05 | 193 | 49 | 4 | 70a9aadda83a97e06e9bc2d1327ce60dd3c58767 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-A_(Artery)|356C / Donor, Lineage, Cell class and subclass (all cells) | 6.10e-05 | 194 | 49 | 4 | 2e5b195e02dcd5e9432b9a98b22e0478e65b9ba2 | |
| ToppCell | nucseq-Mesenchymal-Myocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.10e-05 | 194 | 49 | 4 | 2d66091097e106c7bee22e5281f50724700bdf8d | |
| ToppCell | (6)_Endothelial-B_(Artery)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 6.10e-05 | 194 | 49 | 4 | 0cf4e67d4024652794b5bfdd4a71a7d98900b4c8 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-A_(Artery)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 6.10e-05 | 194 | 49 | 4 | b6b5b0ab506b05a005ba8a05a3c7f4c725ba9200 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_endothelial-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.10e-05 | 194 | 49 | 4 | ea5e1bc8d9e27cabfe1fb833ca47ec0893593b12 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_endothelial|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.10e-05 | 194 | 49 | 4 | cceb7c88492bb6cd531e1c2651638da1ddf30931 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.22e-05 | 195 | 49 | 4 | 78cfde21dde4b877fc76c8b0d5ddaabe44b912d7 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.22e-05 | 195 | 49 | 4 | 4658fb197657d7692ee344ae76b11b0210c418ba | |
| ToppCell | COVID-19-Heart-Low_count_Fib|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.22e-05 | 195 | 49 | 4 | e09590d1f51d5fa57fceb84c9f48f84b23d4d224 | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 6.22e-05 | 195 | 49 | 4 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.22e-05 | 195 | 49 | 4 | df409f94f4e83be89f7a608058ee07ce3ce3a149 | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Endothelial-endothelial_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.22e-05 | 195 | 49 | 4 | 4db30b3bc65c25626f828cd4f867f20c71809898 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.22e-05 | 195 | 49 | 4 | 4243190ad291d56694e2155954dbaa879c9d3844 | |
| ToppCell | (6)_Endothelial-D|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 6.22e-05 | 195 | 49 | 4 | c0005a5f2dc63a0cc254c45ac89a2f42df6f8bde | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.22e-05 | 195 | 49 | 4 | fc43cd295f2cc3f6e9442232e028944f011c82cc | |
| ToppCell | Endothelial|World / shred by cell class for bronchial biopsy | 6.22e-05 | 195 | 49 | 4 | f0e46e859f7a9bdead3203889f7e20fa21f76ff0 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 6.22e-05 | 195 | 49 | 4 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | droplet-Bladder-nan-24m-Endothelial|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.35e-05 | 196 | 49 | 4 | 9a90dd26e7a43e3fd55e7c5d8354cfa4cdd5a6cc | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M|organoid_Kanton_Nature / Sample Type, Dataset, Time_group, and Cell type. | 6.35e-05 | 196 | 49 | 4 | 1e9ccbd5be7839a74108f0cd07a6d2d736bc7f1b | |
| ToppCell | PND28-Mesenchymal|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.35e-05 | 196 | 49 | 4 | 119265efd2219f328d8152dbee52af8327aec89c | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.35e-05 | 196 | 49 | 4 | 42e9828222a9663525d571633e8a454c30bfa7f8 | |
| ToppCell | droplet-Bladder-nan-24m-Endothelial-endothelial_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.35e-05 | 196 | 49 | 4 | 04dfef1bd4ebb0e9469ae80024dc177e469a2560 | |
| ToppCell | Parenchyma_Control_(B.)-Endothelial-TX-Endothelial-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 6.47e-05 | 197 | 49 | 4 | f969685dee212f33a6f09e54c0cd1fd24ffef546 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.47e-05 | 197 | 49 | 4 | ab5d3ebc73bd7cfc64381d14b92878b370205186 | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial-Endothelial-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.47e-05 | 197 | 49 | 4 | 1a137af40697137bb9d2b5caf2b1ffda55f04461 | |
| ToppCell | distal-Endothelial-Bronchial_Vessel_1-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.47e-05 | 197 | 49 | 4 | 0d1afd1ad7489c071db08b3dfff598423097d7e0 | |
| ToppCell | droplet-Bladder-nan-24m-Endothelial-endothelial_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.47e-05 | 197 | 49 | 4 | 488e85991c5e668afb7672942726d9295b8fc7d8 | |
| Computational | Metal / Ca ion binding. | 2.52e-05 | 133 | 29 | 5 | MODULE_324 | |
| Computational | Adhesion molecules. | 3.33e-05 | 141 | 29 | 5 | MODULE_122 | |
| Drug | lead stearate | 2.28e-08 | 84 | 48 | 6 | CID000061258 | |
| Drug | Saquinavir mesylate [149845-06-7]; Up 200; 5.2uM; HL60; HT_HG-U133A | 3.63e-06 | 198 | 48 | 6 | 6127_UP | |
| Drug | AC1L1GUQ | 3.73e-06 | 50 | 48 | 4 | CID000003849 | |
| Drug | A25152 | 8.87e-06 | 62 | 48 | 4 | CID000002956 | |
| Drug | gamma-secretase inhibitor I | 2.60e-05 | 4 | 48 | 2 | CID011754711 | |
| Drug | peptidomimetic inhibitor | 4.91e-05 | 190 | 48 | 5 | CID005288092 | |
| Drug | Adamantamine fumarate [80789-67-9]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 5.70e-05 | 196 | 48 | 5 | 4806_UP | |
| Drug | Delcorine; Up 200; 8.4uM; MCF7; HT_HG-U133A | 5.83e-05 | 197 | 48 | 5 | 4737_UP | |
| Drug | (-)-MK 801 hydrogen maleate [77086-19-2]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 5.98e-05 | 198 | 48 | 5 | 5003_UP | |
| Drug | vgBE | 6.49e-05 | 6 | 48 | 2 | CID000193461 | |
| Disease | connective tissue disease (implicated_via_orthology) | 7.44e-06 | 3 | 47 | 2 | DOID:65 (implicated_via_orthology) | |
| Disease | Colorectal Carcinoma | 1.37e-05 | 702 | 47 | 8 | C0009402 | |
| Disease | scoliosis (is_implicated_in) | 1.49e-05 | 4 | 47 | 2 | DOID:0060249 (is_implicated_in) | |
| Disease | adenocarcinoma (implicated_via_orthology) | 5.19e-05 | 7 | 47 | 2 | DOID:299 (implicated_via_orthology) | |
| Disease | central nervous system cancer (implicated_via_orthology) | 5.19e-05 | 7 | 47 | 2 | DOID:3620 (implicated_via_orthology) | |
| Disease | cancer (implicated_via_orthology) | 6.69e-05 | 268 | 47 | 5 | DOID:162 (implicated_via_orthology) | |
| Disease | aortic aneurysm | 1.11e-04 | 10 | 47 | 2 | EFO_0001666 | |
| Disease | intraocular pressure measurement | 1.51e-04 | 509 | 47 | 6 | EFO_0004695 | |
| Disease | Mammary Carcinoma, Human | 1.78e-04 | 525 | 47 | 6 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 1.78e-04 | 525 | 47 | 6 | C1257931 | |
| Disease | Mammary Neoplasms | 1.82e-04 | 527 | 47 | 6 | C1458155 | |
| Disease | homostachydrine measurement | 1.92e-04 | 13 | 47 | 2 | EFO_0021164 | |
| Disease | Migraine Disorders | 1.92e-04 | 13 | 47 | 2 | C0149931 | |
| Disease | Breast Carcinoma | 2.03e-04 | 538 | 47 | 6 | C0678222 | |
| Disease | cortical surface area measurement | 2.35e-04 | 1345 | 47 | 9 | EFO_0010736 | |
| Disease | Malignant neoplasm of breast | 2.67e-04 | 1074 | 47 | 8 | C0006142 | |
| Disease | Glioblastoma | 2.75e-04 | 79 | 47 | 3 | C0017636 | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 2.86e-04 | 80 | 47 | 3 | DOID:12930 (implicated_via_orthology) | |
| Disease | acute myeloid leukemia (is_implicated_in) | 3.30e-04 | 84 | 47 | 3 | DOID:9119 (is_implicated_in) | |
| Disease | Giant Cell Glioblastoma | 3.30e-04 | 84 | 47 | 3 | C0334588 | |
| Disease | diet measurement, HOMA-B | 4.17e-04 | 19 | 47 | 2 | EFO_0004469, EFO_0008111 | |
| Disease | Squamous cell carcinoma of esophagus | 4.73e-04 | 95 | 47 | 3 | C0279626 | |
| Disease | Carcinoma, Pancreatic Ductal | 6.70e-04 | 24 | 47 | 2 | C0887833 | |
| Disease | Glioblastoma Multiforme | 7.45e-04 | 111 | 47 | 3 | C1621958 | |
| Disease | brain cancer (implicated_via_orthology) | 7.88e-04 | 26 | 47 | 2 | DOID:1319 (implicated_via_orthology) | |
| Disease | retinitis pigmentosa (implicated_via_orthology) | 8.50e-04 | 27 | 47 | 2 | DOID:10584 (implicated_via_orthology) | |
| Disease | complement factor H-related protein 2 measurement | 9.81e-04 | 29 | 47 | 2 | EFO_0600055 | |
| Disease | colorectal cancer (implicated_via_orthology) | 1.05e-03 | 30 | 47 | 2 | DOID:9256 (implicated_via_orthology) | |
| Disease | spontaneous coronary artery dissection | 1.12e-03 | 31 | 47 | 2 | EFO_0010820 | |
| Disease | intestinal cancer (implicated_via_orthology) | 1.19e-03 | 32 | 47 | 2 | DOID:10155 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ACSGDGGVSYTQGQS | 21 | Q6P1X6 | |
| VSGNCGISDSGYTQC | 521 | Q99965 | |
| ASRPGSQEGCYSGCS | 586 | Q9Y2D8 | |
| NGATCSNSGQRSYTC | 296 | Q9NR61 | |
| CNTGSRCRNFSYEGS | 76 | Q86UQ4 | |
| GNVCVGSGARSSFSC | 31 | Q7Z3Y9 | |
| RCASGFTGEDCQYST | 91 | P0DPK3 | |
| RCASGFTGEDCQYST | 91 | Q04721 | |
| RTGSSQSSCCGQYGS | 371 | Q5D862 | |
| QSSCCGQYGSGGSQS | 376 | Q5D862 | |
| NGGTCIESGTSVYCN | 2621 | Q5T1H1 | |
| RNGGECTVNGTTFSC | 2906 | Q5T1H1 | |
| QNGGTCINGRTSFTC | 1051 | Q13201 | |
| CSNGGTCYDSGDTFR | 721 | Q9Y219 | |
| VYGTCSQLCTNTDGS | 156 | Q07954 | |
| RVSTNQCSGYGSGEG | 461 | A6NKB5 | |
| CRNGGTCRQSGDLTY | 206 | Q9UM47 | |
| TQGSFLCQCGRGYTG | 411 | Q9UM47 | |
| CNVDSCSVSSGYGTF | 36 | Q99550 | |
| GTYTCVASNAGGNDT | 476 | P0C6S8 | |
| NGERCGASSFTCSNG | 2696 | P98164 | |
| TGEYTCTCGSQATSA | 3956 | Q5VST9 | |
| SICGNSSSQSSCSYG | 1576 | Q92794 | |
| DCSRTCGGGVQFSSR | 531 | O75173 | |
| GATCTNTGQGSYTCS | 301 | O00548 | |
| RGSYTCECNDGFTAS | 2311 | P35555 | |
| GGTVYRSGESFQSSC | 106 | P29279 | |
| AESCGSGNSTGYQIR | 281 | Q9H2U1 | |
| SGGYQCTCLSQFTGR | 4041 | Q8TDW7 | |
| CASQRNESCGGTFGI | 66 | Q9NZV1 | |
| EAYGQTECTGGCTFT | 441 | Q9ULC5 | |
| CTNCTTSAGRNVGNG | 96 | Q9H992 | |
| STTSCCQYDLCNGTG | 81 | P0DP58 | |
| LQGYTGTQCGECSTG | 941 | A4D0S4 | |
| SCSSLGCGSNGFRYL | 116 | Q3SY46 | |
| YRCECNEGFQSSSSG | 2361 | P35556 | |
| ENRYSCNCTGSGFTG | 281 | P82279 | |
| SANAGYCASLTSCSG | 131 | P48304 | |
| RTTTCFGDGCQNTAS | 4131 | Q685J3 | |
| RTCSDCSQGQGGFTV | 2486 | P08F94 | |
| STGSLYQCQSGTGHC | 66 | P20701 | |
| SGAQCITCSYKASSG | 336 | Q08945 | |
| EGYGQTECTAGCTFT | 456 | Q9UKU0 | |
| RLSTTYFNCTGGLCG | 836 | O75443 | |
| ASCGGGSQSRSVYCI | 376 | O95428 | |
| GQRGSSSGSCSQECG | 1031 | O95759 | |
| CTEVSNQGVYGSCST | 571 | Q9ULT6 | |
| ACGTISSTCGQIASY | 381 | Q9BV35 | |
| RTCDAFTYTGCGGND | 181 | P48307 | |
| DCYTSARGCTATLGN | 221 | P15880 | |
| ACQVTAGGSSQCYRG | 511 | Q9UNY4 | |
| SDTSTGGCQGSYRCQ | 36 | Q9UPR5 |